Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Top Cited Papers
- 14 October 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (21), 6752-6756
- https://doi.org/10.1021/jm901241e
Abstract
The medicinal chemistry community has become increasingly aware of the value of tracking calculated physical properties such as molecular weight, topological polar surface area, rotatable bonds, and hydrogen bond donors and acceptors. We hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose molecules to fail by steering discovery efforts toward achiral, aromatic compounds. We have proposed two simple and interpretable measures of the complexity of molecules prepared as potential drug candidates. The first is carbon bond saturation as defined by fraction sp3 (Fsp3) where Fsp3 = (number of sp3 hybridized carbons/total carbon count). The second is simply whether a chiral carbon exists in the molecule. We demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compounds transition from discovery, through clinical testing, to drugs. In an attempt to explain these observations, we further demonstrate that saturation correlates with solubility, an experimental physical property important to success in the drug discovery setting.Keywords
This publication has 34 references indexed in Scilit:
- Synthesis of Natural‐Product‐Like Molecules with Over Eighty Distinct ScaffoldsAngewandte Chemie, 2008
- Generation of a Set of Simple, Interpretable ADMET Rules of ThumbJournal of Medicinal Chemistry, 2008
- Medicinal chemical properties of successful central nervous system drugsNeuroRX, 2005
- Diversity-oriented synthesis: exploring the intersections between chemistry and biologyNature Chemical Biology, 2005
- A Bioavailability ScoreJournal of Medicinal Chemistry, 2005
- Exploring New Chemical Space by Stereocontrolled Diversity-Oriented SynthesisCell Chemical Biology, 2005
- A Planning Strategy for Diversity‐Oriented SynthesisAngewandte Chemie, 2003
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Target-Oriented and Diversity-Oriented Organic Synthesis in Drug DiscoveryScience, 2000
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997